Page last updated: 2024-10-28

ifenprodil and Infarction, Middle Cerebral Artery

ifenprodil has been researched along with Infarction, Middle Cerebral Artery in 2 studies

ifenprodil: NMDA receptor antagonist

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Yao, H1
Liu, W1
Liao, H1
Sheng, T1
Chen, P1
Zhou, H1
Pan, Y1
Xie, J1
Zhang, Q1
Zou, Z1
Chen, Z1
Picconi, B1
Tortiglione, A1
Barone, I1
Centonze, D1
Gardoni, F1
Gubellini, P1
Bonsi, P1
Pisani, A1
Bernardi, G1
Di Luca, M1
Calabresi, P1

Other Studies

2 other studies available for ifenprodil and Infarction, Middle Cerebral Artery

ArticleYear
Geniposide attenuates postischemic long-term potentiation via GluN2A.
    Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3

    Topics: Animals; Apoptosis; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocamp

2021
NR2B subunit exerts a critical role in postischemic synaptic plasticity.
    Stroke, 2006, Volume: 37, Issue:7

    Topics: Animals; Brain Damage, Chronic; Cerebral Infarction; Cerebrovascular Circulation; Corpus Striatum; D

2006